loader image

Cervical Cancer Screening

Human papillomavirus (HPV) is a common virus transmitted through sexual contact. High Risk subtypes of HPV (HR-HPV) are linked to the development of abnormal cells and can cause cervical cancer.

HPV is a necessary cause of invasive cervical cancer. Evidence shows HPV testing is a more effective way to identify women at risk of cervical cancer than by testing microscopically for abnormal cells from a PAP smear.

What's Included

HR-HPV testing has been used in the UK since 2011 to identify women with low grade cytology
abnormalities and as a follow up test of cure in women who have received treatment.

In 2017 the UK NHSCSP recommended that testing for HPV should replace cytology as the first (primary test) in cervical screening. Primary HR-HPV testing has higher sensitivity for high grade CIN than primary cytology. HR-HPV testing also has a lower false negative rate than cytology.

Primary HR-HPV testing was fully implemented in the UK during 2020. Sample taking remains unchanged: HR-HPV testing is carried out by taking a swab of the cervix. This can be done by a clinician or by self-collection sample.

HPV testing is the FIRST LINE TEST. It will be carried out as a single test, with a single result reported as DETECTED/NOT DETECTED.

• If HR-HPV is NEGATIVE (NOT DETECTED) – this means no further testing is needed.

• If HR-HPV is POSITIVE (DETECTED) – this means that CYTOLOGY will be processed from the same sample.

• If the CYTOLOGY result from this sample is HR-HPV NOT DETECTED – the patient recall will be determined by the screening history and will either be a repeat HR-HPV test in 12 months’ time or, if HR-HPV remains persistent, a referral to colposcopy will be recommended.

• If the CYTOLOGY result from this sample is ABNORMAL the recommendation is to refer for COLPOSCOPY.

Test done by a clinician: Includes in-person appointment, all lab testing, written report and telephone follow-up.

Total £179.25 / Reference HPVH + PHLEBFU

Self-collection sample: We can send you a self-collection kit with detailed instructions for you to take a sample in the comfort and privacy of your own home.

Self-collection of specimens for HPV testing is not intended to replace screening but allows for:

• Those who wish to test following a change of sexual partner
• Option for identifying individual high risk DNA subtypes
• Personal preference to self-collect vaginal samples
• An acceptable option for women who avoid having regular cervical smears
• Self-collection for HPV increases acceptability and coverage rate of cervical cancer prevention

Total £99 / Reference HPVY: Includes delivery of kit, return packaging and cost, laboratory testing and written report. This cost does not include a follow-up with a clinician which can be booked from £49.

drew-hays-tGYrlchfObE-unsplash copy

Cervical Cancer Screening

Human papillomavirus (HPV) is a common virus transmitted through sexual contact. High Risk subtypes of HPV (HR-HPV) are linked to the development of abnormal cells and can cause cervical cancer.

HPV is a necessary cause of invasive cervical cancer. Evidence shows HPV testing is a more effective way to identify women at risk of cervical cancer than by testing microscopically for abnormal cells from a PAP smear.

What's Included

HR-HPV testing has been used in the UK since 2011 to identify women with low grade cytology
abnormalities and as a follow up test of cure in women who have received treatment.

In 2017 the UK NHSCSP recommended that testing for HPV should replace cytology as the first (primary test) in cervical screening. Primary HR-HPV testing has higher sensitivity for high grade CIN than primary cytology. HR-HPV testing also has a lower false negative rate than cytology.

Primary HR-HPV testing was fully implemented in the UK during 2020. Sample taking remains unchanged: HR-HPV testing is carried out by taking a swab of the cervix. This can be done by a clinician or by self-collection sample.

HPV testing is the FIRST LINE TEST. It will be carried out as a single test, with a single result reported as DETECTED/NOT DETECTED.

• If HR-HPV is NEGATIVE (NOT DETECTED) – this means no further testing is needed.

• If HR-HPV is POSITIVE (DETECTED) – this means that CYTOLOGY will be processed from the same sample.

• If the CYTOLOGY result from this sample is HR-HPV NOT DETECTED – the patient recall will be determined by the screening history and will either be a repeat HR-HPV test in 12 months’ time or, if HR-HPV remains persistent, a referral to colposcopy will be recommended.

• If the CYTOLOGY result from this sample is ABNORMAL the recommendation is to refer for COLPOSCOPY.

Test done by a clinician: Includes in-person appointment, all lab testing, written report and telephone follow-up.

Total £179.25 / Reference HPVH + PHLEBFU

Self-collection sample: We can send you a self-collection kit with detailed instructions for you to take a sample in the comfort and privacy of your own home.

Self-collection of specimens for HPV testing is not intended to replace screening but allows for:

• Those who wish to test following a change of sexual partner
• Option for identifying individual high risk DNA subtypes
• Personal preference to self-collect vaginal samples
• An acceptable option for women who avoid having regular cervical smears
• Self-collection for HPV increases acceptability and coverage rate of cervical cancer prevention

Total £99 / Reference HPVY: Includes delivery of kit, return packaging and cost, laboratory testing and written report. This cost does not include a follow-up with a clinician which can be booked from £49.

drew-hays-tGYrlchfObE-unsplash copy

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!